Innovators: It’s Time to Tell Your Stories!
The Healthcare Innovation Innovator Awards Program is open for reader submissions
Read More
How will CMS administer the IRA Medicare Drug Price Negotiation under Trump?
Some hints–and only hints–were provided in a CMS press release on Wednesday. Lowering the cost of prescription drugs for Americans is a top priority of President Trump and his Administration. In accordance with the statutory requirements of the Inflation Reduction Act, the Centers for Medicare and Medicaid Services (CMS) released the list of 15 drugs…
A Look at Federal Health Data Taken Offline
This post looks at federal government databases with key health data that went offline on Jan. 31, 2025, including several related to HIV, some of which had returned by Feb. 2, 2025. It briefly describing the affected databases, which include widely used, large-scale national health surveys, indices, and data dashboards, that inform research, policy making,…
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
Investors showed appetite for Metsera’s IPO, as shares of the clinical-stage metabolic medicines biotech popped 47% in their Nasdaq debut. Maze Therapeutics and Beta Bionics also priced IPOs; the three companies raised $636 million combined. The post Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s appeared first on MedCity…
Why Telehealth Advocates Are Calling on the Trump Administration to Withdraw New Telemedicine Rules
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care. The post Why Telehealth Advocates Are Calling on the Trump Administration to Withdraw New Telemedicine Rules appeared first on MedCity News.
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
As the pharmaceutical landscape evolves, small-molecule CDMOs will be essential in balancing supply and demand, driving innovation, and improving patient outcomes. They must continue embracing innovation and strategic agility to survive and thrive in this complex environment. The post Building Resilience: CDMO Strategies for Drug Supply Chain Stability appeared first on MedCity News.
From Addiction to Advocacy: A Physician’s Journey to Recovery and Helping Others Heal
We need to stop blaming those who struggle with addiction and start helping them. Recovery is possible, but only if we’re willing to support each other. Here is one physician’s recovery story. The post From Addiction to Advocacy: A Physician’s Journey to Recovery and Helping Others Heal appeared first on MedCity News.
Journalists Analyze Issues of the Day: RFK Jr., Bird Flu, L.A. Fires
KFF Health News senior correspondent Arthur Allen discussed what to watch for in Robert F. Kennedy Jr.’s confirmation hearings for secretary of Health and Human Services on CBS News Chicago on Jan. 29. Click here to watch Allen on CBS News Chicago Read Allen’s “What RFK Jr. Might Face in His Nomination Hearings This Week”…
Improving the External Validity of Conjoint Analysis
What is the impact of changing one treatment attribute on patient preferences for that treatment? This is a key question of interest for many patient preference studies. In practice, this is most often done by estimating the causal effect of changing one attribute of a profile while averaging over the distribution of the remaining profile…
MedCity Pivot Podcast: Embedding a New Data Safety Standard in Healthcare
We kick off our first season of the MedCity Pivot Podcast by discussing ways healthcare organizations can protect themselves from being targets of a cybersecurity attack. A new IEEE Standard can help. The post MedCity Pivot Podcast: Embedding a New Data Safety Standard in Healthcare appeared first on MedCity News.